nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.0794	0.153	CbGpPWpGaD
Hydralazine—RYR2—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.0794	0.153	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—CLCN4—nephrolithiasis	0.0518	0.0998	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—CLCN5—nephrolithiasis	0.0518	0.0998	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.042	0.0809	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.0407	0.0784	CbGpPWpGaD
Hydralazine—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0254	0.077	CcSEcCtD
Hydralazine—AOC3—nephron tubule—nephrolithiasis	0.0216	0.142	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0205	0.0395	CbGpPWpGaD
Hydralazine—AOC3—renal system—nephrolithiasis	0.0196	0.129	CbGeAlD
Hydralazine—AOC3—kidney—nephrolithiasis	0.019	0.125	CbGeAlD
Hydralazine—AOC3—cortex of kidney—nephrolithiasis	0.0185	0.122	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.018	0.0348	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.018	0.0348	CbGpPWpGaD
Hydralazine—P4HA1—nephron tubule—nephrolithiasis	0.0172	0.114	CbGeAlD
Hydralazine—CYP3A4—urine—nephrolithiasis	0.017	0.112	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0161	0.031	CbGpPWpGaD
Hydralazine—P4HA1—renal system—nephrolithiasis	0.0157	0.103	CbGeAlD
Hydralazine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.015	0.0456	CcSEcCtD
Hydralazine—P4HA1—cortex of kidney—nephrolithiasis	0.0148	0.0974	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0147	0.0283	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0147	0.0283	CbGpPWpGaD
Hydralazine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0436	CcSEcCtD
Hydralazine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0387	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0111	0.0215	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0111	0.0215	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0104	0.02	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0104	0.02	CbGpPWpGaD
Hydralazine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0307	CcSEcCtD
Hydralazine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.01	0.0304	CcSEcCtD
Hydralazine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00992	0.0301	CcSEcCtD
Hydralazine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00937	0.0284	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00923	0.0178	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00923	0.0178	CbGpPWpGaD
Hydralazine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00814	0.0247	CcSEcCtD
Hydralazine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00761	0.0231	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00738	0.0142	CbGpPWpGaD
Hydralazine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0222	CcSEcCtD
Hydralazine—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0222	CcSEcCtD
Hydralazine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00683	0.0207	CcSEcCtD
Hydralazine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00679	0.0206	CcSEcCtD
Hydralazine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0205	CcSEcCtD
Hydralazine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0201	CcSEcCtD
Hydralazine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0197	CcSEcCtD
Hydralazine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00625	0.019	CcSEcCtD
Hydralazine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0189	CcSEcCtD
Hydralazine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0176	CcSEcCtD
Hydralazine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00523	0.0159	CcSEcCtD
Hydralazine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0051	0.0155	CcSEcCtD
Hydralazine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00505	0.0153	CcSEcCtD
Hydralazine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00503	0.0153	CcSEcCtD
Hydralazine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.005	0.0152	CcSEcCtD
Hydralazine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0149	CcSEcCtD
Hydralazine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00487	0.0148	CcSEcCtD
Hydralazine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00481	0.0146	CcSEcCtD
Hydralazine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00463	0.0141	CcSEcCtD
Hydralazine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00463	0.0141	CcSEcCtD
Hydralazine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00462	0.014	CcSEcCtD
Hydralazine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0139	CcSEcCtD
Hydralazine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00444	0.0135	CcSEcCtD
Hydralazine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0132	CcSEcCtD
Hydralazine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00433	0.0132	CcSEcCtD
Hydralazine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00423	0.0128	CcSEcCtD
Hydralazine—CYP3A4—renal system—nephrolithiasis	0.00416	0.0274	CbGeAlD
Hydralazine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00415	0.0126	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00405	0.0123	CcSEcCtD
Hydralazine—CYP3A4—kidney—nephrolithiasis	0.00402	0.0265	CbGeAlD
Hydralazine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00399	0.0121	CcSEcCtD
Hydralazine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00396	0.012	CcSEcCtD
Hydralazine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00391	0.0119	CcSEcCtD
Hydralazine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00386	0.0117	CcSEcCtD
Hydralazine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0038	0.0115	CcSEcCtD
Hydralazine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00366	0.0111	CcSEcCtD
Hydralazine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00353	0.0107	CcSEcCtD
Hydralazine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00351	0.0107	CcSEcCtD
Hydralazine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00993	CcSEcCtD
Hydralazine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00954	CcSEcCtD
Hydralazine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00922	CcSEcCtD
Hydralazine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00891	CcSEcCtD
Hydralazine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00857	CcSEcCtD
Hydralazine—Rash—Hydrochlorothiazide—nephrolithiasis	0.0028	0.0085	CcSEcCtD
Hydralazine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00849	CcSEcCtD
Hydralazine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00278	0.00844	CcSEcCtD
Hydralazine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00801	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00145	0.00279	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000327	0.00063	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000291	0.000562	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000248	0.000478	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000248	0.000478	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000177	0.00034	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.00016	0.000308	CbGpPWpGaD
